WHAT THE TWO PARTS DID IN STUDIES
BPC-157 TB-500: what happened in rats, and what don’t we know?
Rat work supplies most findings for BPC-157 and TB-500. Each substance was studied alone. The combined product remains untested.
A glazed-tile reading panel on the BPC-157 TB-500 blend — every tendon, wound, and angiogenesis study set in its place, with the regulatory and compounding-access record laid out in the open.
What did each part do in the studies?
Researchers and sellers call BPC-157 TB-500 the Wolverine blend. BPC-157 is a 15-amino-acid chain, built from small protein parts. Scientists list its weight as 1419 daltons, a lab unit used to tell substances apart [1].
TB-500 is a much shorter piece of Thymosin Beta-4. Its lab weight is 889 daltons [3]. The weight helps identify the substance. It doesn't tell whether an injury will heal.
BPC-157 helped blood return to injured rat muscle [2]. Tiny blood vessels near the injury carried that blood. TB-500 may work with actin, a cell protein used during shape changes. This BPC-157 test was separate from the actin test.
A dish test found a 1:1 hold between TB-500 and actin [3]. That means one short protein part held a single actin part. The test didn't show healing in an animal or person. It only showed how the two pieces met in a dish.
A 2025 review covered 36 BPC-157 studies. Only one involved people, and useful safety facts were missing [9]. The federal pharmacy record explains the current rules. No source tested the two-part blend.
What does BPC 157 TB 500 mean when sold together?
BPC 157 TB 500 puts two separately studied parts in one blend. BPC-157 may protect hurt tissue and support growth of new blood vessels. TB-500 may guide repair cells toward hurt tissue. No study has found a larger effect from the pair.
Sellers call the hoped-for added effect “synergy.” They mean each part might help the other work. Published research gives no tested dose or proof for that claim. The separate study findings list the result for each part [2][3].
For you, the substance named in each study matters. A result for one part applies only to that part. The blend needs its own study. A BPC-157 TB-500 blend study hasn't happened.
What does BPC-157 TB-500 stack mean?
Sellers use BPC-157 TB-500 stack for the two parts sold together. The mix isn't an approved medicine. Some vials list 10 mg of BPC-157 and 10 mg of TB-500. Human research gives no proof for that mix [1].
No study sets how much of each part belongs together. Scientists list sold TB-500 at 889 daltons. Most studies used full Thymosin Beta-4, at 4963 daltons [4][8]. The large weight gap shows that researchers used a different substance, so the animal study amounts do not set a human dose.
Which injuries were studied for BPC-157 TB-500?
BPC-157 studies used rats with hurt tendons, ligaments, muscles, or skin. TB-500 and Thymosin Beta-4 studies watched repair cells move across wounds [1][5]. Researchers never gave the two parts together. No test studied the full Wolverine blend.
Why do sellers call it the Wolverine blend?
Sellers use Wolverine as the name for this two-part mix. BPC-157 is a lab-made 15-amino-acid chain. It came from work on a stomach protein. TB-500 comes from Thymosin Beta-4, but the nickname doesn’t make either part an approved drug [1].
How are BPC-157 and TB-500 different?
BPC-157 came from work on a stomach protein. Its lab weight is 1419 daltons [1]. TB-500 comes from Thymosin Beta-4 and weighs 889 daltons [3][8]. These numbers identify two different substances; they don’t show that either one heals people.
Which results were clearest, and what is missing?
The clearest BPC-157 results came from that part alone. For every kilogram a rat weighed, it received 10 millionths of a gram. Their cut Achilles tendons became stronger [1]. BPC-157 also restored blood flow in injured rat muscle [2].
Compared with untreated rat wounds, full Thymosin Beta-4 increased new skin cover by 42% at 4 days. It increased that cover by 61% at 7 days [5]. A dish test found a 1:1 hold between TB-500 and actin [3]. That lab result measured no healing in a body.
A 2025 review covered 36 BPC-157 studies. Only one involved people. Useful human safety facts were missing, and the review didn't cover TB-500 [9]. Other human facts on either part also remain thin [4][8].
The missing BPC-157 TB-500 test is the main gap. The separate study results cover each part. The BPC-157 TB-500 wound healing research explains the rat wound numbers. The federal pharmacy record covers access rules.
Animal findings can't predict your response, and short TB-500 still lacks human proof. No test in people has found a benefit, safe amount, or safety record. A seller's claim can't fill those gaps. Your doctor has no blend trial to rely on.
What effects and safety problems have people described?
People online describe changes after trying the blend. Their stories cannot prove the blend was the cause. The effects and risks page separates those stories from study findings. It gives no dose or promise of benefit.